A comprehensive systematic review published in the Cochrane Database analyzed 14 randomized clinical trials with over 100,000 participants, conclusively demonstrating that RSV vaccines have robust safety profiles and are effective in preventing RSV infections. This evidence reinforces the vaccines' utility for vulnerable populations, supporting broad adoption in public health programs to reduce the burden of RSV-related respiratory illnesses.